CTI’s 1H25 guidance indicates revenue and EBITDA slightly above expectations. However, investments in support of future growth have increased depreciation and interest expenses above prior assumptions, and our PBT forecast is revised down accordingly. CTI is well positioned for growth, and we maintain a BUY call on a $2.75 valuation (prior $2.85).
To access the full report please log in under the Research Portal at the bottom of this page.
Argonaut’s Research Portal allows you to access Argonaut’s wealth of Research, as well as view descriptions of the Morning Note, Companies covered and the Team.
If you would like to access our research please contact us to create an account.
